Lopinavir and Adagrasib Inhibit CYP2C9-Mediated Bosentan Metabolism in Laboratory Models
Researchers demonstrated that lopinavir and adagrasib inhibit CYP2C9-mediated bosentan metabolism across microsomal systems, molecular models, and rat pharmacokinetic studies.

